AbCellera Biologics (ABCL) Prepaid Assets: 2020-2025

Historic Prepaid Assets for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $133.0 million.

  • AbCellera Biologics' Prepaid Assets rose 206.68% to $133.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.0 million, marking a year-over-year increase of 206.68%. This contributed to the annual value of $67.1 million for FY2024, which is 20.30% up from last year.
  • According to the latest figures from Q3 2025, AbCellera Biologics' Prepaid Assets is $133.0 million, which was up 13.92% from $116.8 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Prepaid Assets ranged from a high of $133.0 million in Q3 2025 and a low of $5.7 million during Q1 2021.
  • For the 3-year period, AbCellera Biologics' Prepaid Assets averaged around $76.6 million, with its median value being $67.1 million (2024).
  • Per our database at Business Quant, AbCellera Biologics' Prepaid Assets surged by 600.81% in 2022 and then crashed by 43.01% in 2024.
  • Quarterly analysis of 5 years shows AbCellera Biologics' Prepaid Assets stood at $21.2 million in 2021, then skyrocketed by 254.93% to $75.4 million in 2022, then fell by 25.99% to $55.8 million in 2023, then grew by 20.30% to $67.1 million in 2024, then spiked by 206.68% to $133.0 million in 2025.
  • Its Prepaid Assets was $133.0 million in Q3 2025, compared to $116.8 million in Q2 2025 and $94.7 million in Q1 2025.